Correlation Between Genmab AS and Scilex Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Scilex Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Scilex Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Scilex Holding, you can compare the effects of market volatilities on Genmab AS and Scilex Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Scilex Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Scilex Holding.

Diversification Opportunities for Genmab AS and Scilex Holding

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Genmab and Scilex is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Scilex Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scilex Holding and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Scilex Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scilex Holding has no effect on the direction of Genmab AS i.e., Genmab AS and Scilex Holding go up and down completely randomly.

Pair Corralation between Genmab AS and Scilex Holding

Given the investment horizon of 90 days Genmab AS is expected to generate 0.24 times more return on investment than Scilex Holding. However, Genmab AS is 4.1 times less risky than Scilex Holding. It trades about -0.14 of its potential returns per unit of risk. Scilex Holding is currently generating about -0.22 per unit of risk. If you would invest  2,232  in Genmab AS on September 1, 2024 and sell it today you would lose (116.00) from holding Genmab AS or give up 5.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy95.45%
ValuesDaily Returns

Genmab AS  vs.  Scilex Holding

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Scilex Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scilex Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Genmab AS and Scilex Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Scilex Holding

The main advantage of trading using opposite Genmab AS and Scilex Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Scilex Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scilex Holding will offset losses from the drop in Scilex Holding's long position.
The idea behind Genmab AS and Scilex Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments